Prof. Siddappa Byrareddy | Immunology and Microbiology | Best Researcher Award
professor. Siddappa Byrareddy, University of Nebraska Medical Center, United States🎓
Professional Profile
🌟Siddappa N. Byrareddy, Ph.D.
📘 Early Academic Pursuits
Dr. Siddappa N. Byrareddy’s journey into the world of virology and immunology began with a robust academic foundation in India. He completed his Bachelor of Science in Chemistry, Zoology, and Microbiology at Bangalore University in 1997. Following this, he earned a Master of Science in Biotechnology from the same institution in 1999. Dr. Byrareddy then pursued a Ph.D. in HIV Molecular Virology and Neuroscience at the Jawaharlal Nehru Center for Advanced and Scientific Research (JNCASR) & National Institute of Mental Health and Neurosciences (NIMHANS) in Bangalore, completing his doctorate in 2007.
🔬 Contributions and Research Focus
Dr. Byrareddy’s research is deeply rooted in the virology and immunology of infectious diseases, particularly focusing on emerging and re-emerging viruses such as HIV, Zika, SARS-CoV-2, and Mpox. His work emphasizes understanding HIV/SIV reservoirs within the CNS, including T and myeloid cells, and exploring neuroimmunology, infection, inflammation, and viral disease pathogenesis. His research portfolio encompasses viral immunology, epidemiology, the development of animal models for infectious and neurodegenerative diseases, host-virus interactions, Omics Pharmacology, and the pharmacokinetics/pharmacodynamics of antiviral drugs.
🌐 Impact and Influence
Dr. Byrareddy’s research has had a profound impact on the scientific community, especially his work on COVID-19, which has garnered widespread attention and has been referenced in the vaccine development strategies of Moderna and COVAXINTM. His mentorship has guided over 50 individuals, helping them secure admissions to esteemed institutions and independent positions in academia and industry. His collaborative efforts extend across a substantial network of researchers and clinicians at UNMC and internationally.
📈 Legacy and Future Contributions
Dr. Byrareddy’s legacy is marked by his relentless pursuit of scientific breakthroughs in the field of infectious diseases. His ongoing research and collaborative efforts continue to push the boundaries of our understanding of virology and immunology. As he advances in his career, Dr. Byrareddy remains committed to mentoring the next generation of scientists and contributing to significant discoveries that address critical questions in virology and immunology.
📖Publications :
Authors: HA Rothan, SN Byrareddy
Journal: Journal of Autoimmunity
Volume: 109
Issue: –
Pages: 102433
Year: 2020Paper Title: Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase
Authors: K Balasubramanyam, RA Varier, M Altaf, V Swaminathan, NB Siddappa, …
Journal: Journal of Biological Chemistry
Volume: 279
Issue: 49
Pages: 51163-51171
Year: 2004Paper Title: The 2022 outbreak and the pathobiology of the monkeypox virus
Authors: N Kumar, A Acharya, HE Gendelman, SN Byrareddy
Journal: Journal of Autoimmunity
Volume: 131
Issue: –
Pages: 102855
Year: 2022
Paper Title: Impact of social determinants of health on the emerging COVID-19 pandemic in the United States
Authors: S Singu, A Acharya, K Challagundla, SN Byrareddy
Journal: Frontiers in Public Health
Volume: 8
Issue: –
Pages: 406
Year: 2020
Paper Title: Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
Authors: SR Kannan, AN Spratt, AR Cohen, SH Naqvi, HS Chand, TP Quinn, …
Journal: Journal of Autoimmunity
Volume: 124
Issue: –
Pages: 102715
Year: 2021
Paper Title: Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy
Authors: SN Byrareddy, J Arthos, C Cicala, F Villinger, KT Ortiz, D Little, N Sidell, …
Journal: Science
Volume: 354
Issue: 6309
Pages: 197-202
Year: 2016
Paper Title: Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
Authors: SR Kannan, AN Spratt, K Sharma, HS Chand, SN Byrareddy, K Singh
Journal: Journal of Autoimmunity
Volume: 126
Issue: –
Pages: 102779
Year: 2022
Paper Title: Specific inhibition of p300-HAT alters global gene expression and represses HIV replication
Authors: K Mantelingu, BAA Reddy, V Swaminathan, AH Kishore, NB Siddappa, …
Journal: Chemistry & Biology
Volume: 14
Issue: 6
Pages: 645-657
Year: 2007
Paper Title: Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine
Authors: U Ranga, R Shankarappa, NB Siddappa, L Ramakrishna, R Nagendran, …
Journal: Journal of Virology
Volume: 78
Issue: 5
Pages: 2586-2590
Year: 2004
Paper Title: Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques
Authors: PJ Santangelo, KA Rogers, C Zurla, EL Blanchard, S Gumber, K Strait, …
Journal: Nature Methods
Volume: 12
Issue: 5
Pages: 427-432
Year: 2015